Skip to main content
. 2020 May 6;9(13):4622–4631. doi: 10.1002/cam4.3113

Figure 1.

Figure 1

Time to ≥ grade 2 radiation pneumonitis (RP2) in the concurrent chemoradiation alone cohort (cCRT, grey circles) and in the concurrent chemoradiation and consolidative durvalumab cohort (cCRT + durvalumab cohort, orange circles) as well as their cohort median time to RP2 (dashed grey and dashed orange lines, respectively). Note: The cohort median time to Durvalumab start has been inserted as well (black dotted line)